Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023.
On April 25, 2024, the Committee for Medicinal Products for Human Use (“CHMP”) adopted a positive opinion, recommending the granting of marketing authorization for Biogen Netherlands...
Investegate announcements from Truqap recommended for EU breast cancer approval
AstraZeneca announces that Truqap in combination with Faslodex has been recommended by the Committee for Medicinal Products for Human Use of the European Medicines Agency for approval in the...
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License...